Successful prevention of transmission of integrase resistance in the Swiss HIV Cohort Study.

Scherrer, Alexandra U; Yang, Wan-Lin; Kouyos, Roger D; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Cavassini, Matthias; Battegay, Manuel; Hauser, Christoph; Calmy, Alexandra; Schmid, Patrick; Bernasconi, Enos; Günthard, Huldrych F (2016). Successful prevention of transmission of integrase resistance in the Swiss HIV Cohort Study. Journal of infectious diseases, 214(3), pp. 399-402. Oxford University Press 10.1093/infdis/jiw165

Preview	Text infdis.jiw165.full.pdf - Accepted Version Available under License Publisher holds Copyright. Download (865kB) | Preview
	Text infdis.jiw165.full.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (236kB) | Request a copy

Prevalence of integrase inhibitor (INSTI) transmitted drug resistance (TDR) may increase with the increasing use of INSTIs. We analysed the prevalence of INSTI TDR in the Swiss HIV Cohort Study (2008-2014). In 1 of 1,316 (0.1%) drug-naïve samples a major INSTI TDR mutation was detected. Prevalence was stable although INSTIs were increasingly used. We showed that this is in contrast to the introduction of previous drug classes where more treatment failures with resistant strains occurred and TDR was observed more rapidly. We demonstrated on a population-level that it is possible to avoid TDR affecting a new drug class for years.

Interest & Impact

Downloads

172 since deposited on 07 Jul 2016
29 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item